RE: RE: I don't know about everyone elseCould the lack of announcement be indicative of the fact that part of the deal was that ENDO controls and releases all info regarding Urocidin? McRae has stated this before. This new trial out of the blue is material to BNC but not to ENDO. We have now read the many possible reasons the share price took off. BNC forced a halt, (I'm pretty sure of that) and it took them 4 hrs to decide that the trial was ENDO's business and such BNC didn't have to release the news, esspecially because the public has not discivered this new trial yet. I also think that if all the postings last night happened before the 4pm "no news" news, we would have had a different news release.Remember, that I am under the assumption that management is still operating on the basis that the longer the share price stays low, the more stock the employees can accumulate before ENDO is forced to announce the BIG NEWS.